Search

ZOLADEX 3.6 MG, Implant injectable

Details

--- Description
Pack Boîte de 1 Seringue préremplie
Strength (Dosage) 3.6 MG
Laboratory MAPHAR
Ingredients Goséréline acétate
Therapeutic class ANTINEOPLASIQUES CYTOTOXIQUES
ATC code L02AE03
PPH $107.70
PPV $134.60
Refundable Yes
Refund base $134.60
Refund rate $0.00
Table A
Marketing status Commercialized
Type Medication
Uses Zoladex est indiqué chez l’adulte dans le :

· Traitement du cancer de la prostate métastasé.
· Traitement adjuvant à la radiothérapie externe dans le cancer de la prostate localement avancé (stade T3 -T4 de la classification TNM ou stade C de la classification AUA).
Warnings
Dosage
Avoid
Side effects
Interactions

Medications under one or more of the therapeutic classes above


Medications from the same laboratory


Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.